Palatin Technologies Net Receivables Over Time
| PTN Stock | USD 0.88 0.02 2.33% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Palatin Technologies Performance and Palatin Technologies Correlation. Palatin |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palatin Technologies. If investors know Palatin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palatin Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.98) | Revenue Per Share 0.306 | Quarterly Revenue Growth (0.80) | Return On Assets (1.32) | Return On Equity (6.23) |
The market value of Palatin Technologies is measured differently than its book value, which is the value of Palatin that is recorded on the company's balance sheet. Investors also form their own opinion of Palatin Technologies' value that differs from its market value or its book value, called intrinsic value, which is Palatin Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palatin Technologies' market value can be influenced by many factors that don't directly affect Palatin Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palatin Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Palatin Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palatin Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Receivables Analysis
Compare Palatin Technologies and related stocks such as Fortress Biotech, Checkpoint Therapeutics, and Avenue Therapeutics Net Receivables Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FBIO | 349 K | 349 K | 349 K | 156 K | 156 K | 156 K | 8.7 M | 17.4 M | 7.6 M | 14.4 M | 19.3 M | 23.8 M | 28.3 M | 15.4 M | 13.6 M |
| CKPT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 65 K | 821 K | 331 K | 1.5 M | 26 K | 20 K | 17 K | 73 K | 65.7 K | 62.4 K |
| ATXI | 90 K | 90 K | 90 K | 90 K | 90 K | 90 K | 90 K | 90 K | 90 K | 90 K | 90 K | 90 K | 90 K | 81 K | 72 K |
| PIRS | 971.4 K | 971.4 K | 971.4 K | 548.3 K | 14.8 K | 980.9 K | 57.6 K | 15.5 M | 2.7 M | 6.8 M | 1.7 M | 3.3 M | 5.8 M | 572 K | 543.4 K |
| QNRX | 77.3 K | 77.3 K | 77.3 K | 77.3 K | 77.3 K | 77.3 K | 77.3 K | 77.3 K | 77.3 K | 77.3 K | 77.3 K | 77.3 K | 77.3 K | 69.6 K | 61.8 K |
| COCP | 523 K | 523 K | 835 K | 287 K | 287 K | 202 K | 1.3 M | 1.3 M | 644 K | 644 K | 556 K | 0.0 | 716 K | 890 K | 726.3 K |
| IBIO | 145.7 K | 351.4 K | 1 M | 205 K | 445 K | 606 K | 175 K | 75 K | 97 K | 5.6 M | 5.5 M | 6.1 M | 204 K | 713 K | 1.3 M |
| BPTH | 10.3 K | 775.2 K | 775.2 K | 775.2 K | 775.2 K | 775.2 K | 775.2 K | 775.2 K | 775.2 K | 775.2 K | 0.0 | (523) | (3.6 K) | 0.0 | 0.0 |
| AKTX | 21 K | 21 K | 14 K | 175 K | 73 K | 10.4 K | 10.4 M | 10.4 M | 10.4 M | 4.5 M | 3.5 M | 3 M | 3 M | 3.4 M | 2.7 M |
| SLRX | 12 K | 12 K | 12 K | 12 K | 12 K | 12 K | 12 K | 10 K | 10 K | 3.9 M | 3.9 M | 1.6 M | 1.6 M | 1.9 M | 1.2 M |
| HSTO | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 3.4 M | 3.7 M | 110 K | 144 K | 165 K | 99 K | 89.1 K | 84.6 K |
| SABS | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 20.6 M | 8 M | 5.6 M | 0.0 | 0.0 |
| VCNX | 104 K | 104 K | 104 K | 104 K | 104 K | 104 K | 104 K | 117 K | 639 K | 898 K | 157 K | 0.0 | 175 K | 961 K | 1 M |
| GOVX | 2 K | 183.5 K | 266.2 K | 140.9 K | 79.3 K | 120 K | 28.1 K | 59.8 K | 121.8 K | 68.6 K | 182.7 K | 49 K | 49 K | 44.1 K | 41.9 K |
| TNXP | 552 | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 392 K | 494 K | 525 K | 1 M | 7.6 M | 7.7 M | 8 M | 4.6 M | 3.7 M |
| JAGX | 160.9 K | 59.1 K | 59.1 K | 59.1 K | 59.1 K | 59.1 K | 304.6 K | 469 K | 1 M | 1.7 M | 4.6 M | 2.1 M | 2.5 M | 2 M | 1.6 M |
Palatin Technologies and related stocks such as Fortress Biotech, Checkpoint Therapeutics, and Avenue Therapeutics Net Receivables description
My Equities
My Current Equities and Potential Positions
| Palatin Technologies | PTN |
| Classification | Biotech |
| Location | New Jersey; U.S.A |
| Exchange | NYSE MKT Exchange |
USD 0.88
Check out Palatin Technologies Performance and Palatin Technologies Correlation. To learn how to invest in Palatin Stock, please use our How to Invest in Palatin Technologies guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Palatin Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.